Q-Pharm Brisbane

Q-Pharm is a premier Phase 1 clinical trial facility located in Brisbane, Australia, specializing in early-phase clinical research services for the global biotechnology and pharmaceutical industries. Originally established as a subsidiary of the QIMR Berghofer Medical Research Institute, the company operates a high-capacity clinical unit situated within the Royal Brisbane and Women's Hospital precinct. In 2019, Q-Pharm was acquired by Nucleus Network, integrating it into one of the largest Phase 1 clinical trial organizations globally. The facility is renowned for conducting complex first-in-human studies, vaccine trials, and bioanalytical services under strict regulatory standards. Its strategic location provides access to a diverse participant pool and specialized medical expertise, making it a key hub for early-stage drug development in the Asia-Pacific region.